Ananya Choudhury

The University of Manchester - Translational Radiobiology Group

SCHOLARLY PAPERS

5

DOWNLOADS

275

TOTAL CITATIONS

0

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

Comparison of Dose-Response Maps of the Bladder and Rectum in Prostate Cancer Patients Undergoing Radiotherapy With and Without Baseline Toxicity Normalization

Number of pages: 10 Posted: 26 Nov 2024
Tanuj Puri, Ananya Choudhury, Alison M. Dunning, Marie-Pierre Farcy Jacquet, D. de Ruysscher, David Azria, Barbara Avuzzi, Eliana Gioscio, Catharine ML West, Alan McWilliam, Sarah Kerns, Jane Shortall, Maarten Lambrecht, Elena Sperk, Petra Seibold, Marcel van Herk, Jenny Chang-Claude, Adam Webb, Liv Veldeman, Ana Vega, Barry S. Rosenstein, Christopher J Talbot, Eliana Vasquez Osorio, tiziana rancati, Andrew P. Morris, Andrew Green and Peter J. Hoskin
The University of Manchester - Faculty of Biology, Medicine and Health, The University of Manchester - Translational Radiobiology Group, University of Cambridge - Department of Oncology, CHU Nimes, Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre, University of Montpellier - Institut régional du Cancer de Montpellier, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, The University of Manchester - Translational Radiobiology Group, The University of Manchester, Medical College of Wisconsin, The University of Manchester, KU Leuven, University of Heidelberg, German Cancer Research Center (DKFZ), The University of Manchester, German Cancer Research Center (DKFZ), University of Leicester, Ghent University, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Leicester, The University of Manchester, Fondazione IRCCS Istituto Nazionale dei Tumori, The University of Manchester - Centre for Genetics and Genomics Versus Arthritis, European Bioinformatics Institute and The University of Manchester - Translational Radiobiology Group
Downloads 112 (538,301)

Abstract:

Loading...

prostate cancer, radiotherapy, toxicities, side effects, biomarkers, prediction models, voxel-based dose-response analysis, VBA, image-based data mining, IBDM, OAR, bladder, rectum, organ-at-risk

2.

New Rectum Dose Surface Mapping Methodology to Identify Rectal Subregions Associated with Toxicities Following Prostate Cancer Radiotherapy

Number of pages: 19 Posted: 14 Oct 2024
Artemis Bouzaki, Dylan Mir Green, Tanuj Puri, Marcel van Herk, Jane Shortall, Sarah Kerns, David Azria, Marie-Pierre Farcy Jacquet, Jenny Chang-Claude, Ananya Choudhury, Alison M. Dunning, Maarten Lambrecht, Barbara Avuzzi, D. de Ruysscher, Petra Seibold, Elena Sperk, Christopher J Talbot, Ana Vega, Liv Veldeman, Adam Webb, Barry S. Rosenstein, Catharine ML West, Eliana Vasquez Osorio, Alan McWilliam, tiziana rancati and Eliana Gioscio
affiliation not provided to SSRN, University of Oxford, The University of Manchester - Faculty of Biology, Medicine and Health, The University of Manchester, The University of Manchester, Medical College of Wisconsin, University of Montpellier - Institut régional du Cancer de Montpellier, CHU Nimes, German Cancer Research Center (DKFZ), The University of Manchester - Translational Radiobiology Group, University of Cambridge - Department of Oncology, KU Leuven, Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre, German Cancer Research Center (DKFZ), University of Heidelberg, University of Leicester, affiliation not provided to SSRN, Ghent University, University of Leicester, affiliation not provided to SSRN, The University of Manchester - Translational Radiobiology Group, The University of Manchester, The University of Manchester, Fondazione IRCCS Istituto Nazionale dei Tumori and Fondazione IRCCS Istituto Nazionale dei Tumori
Downloads 53 (837,901)

Abstract:

Loading...

Radiotherapy, Prostate Cancer, normal tissue toxicity, dose surface maps, rectum mapping

3.

A Hypoxia Biomarker Does Not Predict Benefit from Giving Chemotherapy with Radiotherapy in the BC2001 Randomised Controlled Trial

Number of pages: 35 Posted: 22 Jun 2023
Tim Andrew Davies Smith, Catharine ML West, Nuradh Joseph, Brian Lane, Joely Irlam-Jones, Elisabet More, Hitesh Mistry, Kimberley J. Reeves, Yee Pei Song, Mark Reardon, Peter J. Hoskin, Syed A. Hussain, Helen Denley, Emma Hall, Porta Nuria, Robert A. Huddart, Nicholas David James and Ananya Choudhury
The University of Manchester - Translational Radiobiology Group, The University of Manchester - Translational Radiobiology Group, Sri Lanka Cancer Research Group, The University of Manchester - Translational Radiobiology Group, The University of Manchester - Translational Radiobiology Group, The University of Manchester - Translational Radiobiology Group, The University of Manchester - Translational Radiobiology Group, The University of Manchester - Translational Radiobiology Group, The University of Manchester - Translational Radiobiology Group, The University of Manchester - Translational Radiobiology Group, The University of Manchester - Translational Radiobiology Group, University of Sheffield - Department of Oncology & Metabolism, Royal Shrewsbury Hospital - Pathology Centre, Institute of Cancer Research (ICR) - Clinical Trials and Statistics Unit (ICR-CTSU), Institute of Cancer Research (ICR) - Clinical Trials and Statistics Unit (ICR-CTSU), Royal Marsden NHS Foundation Trust - Department of Oncology, Royal Marsden NHS Foundation Trust - Department of Oncology and The University of Manchester - Translational Radiobiology Group
Downloads 51 (853,536)

Abstract:

Loading...

Hypoxia, radiotherapy, hypofractionation, BCON, BC2001, chemotherapy, transcriptomics

4.

Dose-Response Mapping of Bladder and Rectum in Prostate Cancer Patients Undergoing Radiotherapy with and Without Baseline Toxicity Normalization

Number of pages: 18 Posted: 18 Mar 2025
Tanuj Puri, tiziana rancati, Petra Seibold, Adam Webb, Eliana Vasquez Osorio, Andrew Green, Eliana Gioscio, David Azria, Marie-Pierre Farcy Jacquet, Jenny Chang-Claude, Alison M. Dunning, Maarten Lambrecht, Barbara Avuzzi, D. de Ruysscher, Elena Sperk, Ana Vega, Liv Veldeman, Barry S. Rosenstein, Jane Shortall, Sarah Kerns, Christopher J Talbot, Andrew P. Morris, Peter Hoskin, Ananya Choudhury, Alan McWilliam, Catharine ML West and Marcel van Herk
The University of Manchester - Faculty of Biology, Medicine and Health, Fondazione IRCCS Istituto Nazionale dei Tumori, German Cancer Research Center (DKFZ), University of Leicester, The University of Manchester, European Bioinformatics Institute, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Montpellier - Institut régional du Cancer de Montpellier, CHU Nimes, German Cancer Research Center (DKFZ), University of Cambridge - Department of Oncology, KU Leuven, Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre, University of Heidelberg, affiliation not provided to SSRN, Ghent University, affiliation not provided to SSRN, The University of Manchester, Medical College of Wisconsin, University of Leicester, The University of Manchester - Centre for Genetics and Genomics Versus Arthritis, Government of the United Kingdom, Department of Health, National Health Service (NHS), Mount Vernon Cancer Centre Northwood, The University of Manchester - Translational Radiobiology Group, The University of Manchester, The University of Manchester - Translational Radiobiology Group and The University of Manchester
Downloads 40 (950,501)

Abstract:

Loading...

multicenter clinical trial, prostate cancer, radiotherapy, toxicities, side effects, biomarkers, prediction models, statistical models, voxel-based dose-response analysis, VBA, image-based data mining, IBDM, organs-at-risk, OAR, bladder, rectum.

5.

Dose-Response Mapping of Bladder and Rectum in Prostate Cancer Patients Undergoing Radiotherapy with and Without Baseline Toxicity Correction

Number of pages: 26 Posted: 28 Apr 2025
Tanuj Puri, tiziana rancati, Petra Seibold, Adam Webb, Andrew Green, Eliana Gioscio, David Azria, Eliana Vasquez Osorio, Marie-Pierre Farcy Jacquet, Jenny Chang-Claude, Alison M. Dunning, Maarten Lambrecht, Barbara Avuzzi, D. de Ruysscher, Elena Sperk, Ana Vega, Liv Veldeman, Barry S. Rosenstein, Jane Shortall, Sarah Kerns, Christopher J Talbot, Andrew P. Morris, Alan McWilliam, Peter Hoskin, Ananya Choudhury, Catharine ML West and Marcel van Herk
The University of Manchester - Faculty of Biology, Medicine and Health, Fondazione IRCCS Istituto Nazionale dei Tumori, German Cancer Research Center (DKFZ), University of Leicester, European Bioinformatics Institute, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Montpellier - Institut régional du Cancer de Montpellier, The University of Manchester, CHU Nimes, German Cancer Research Center (DKFZ), University of Cambridge - Department of Oncology, KU Leuven, Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre, University of Heidelberg, affiliation not provided to SSRN, Ghent University, affiliation not provided to SSRN, The University of Manchester, Medical College of Wisconsin, University of Leicester, The University of Manchester - Centre for Genetics and Genomics Versus Arthritis, The University of Manchester, Government of the United Kingdom, Department of Health, National Health Service (NHS), Mount Vernon Cancer Centre Northwood, The University of Manchester - Translational Radiobiology Group, The University of Manchester - Translational Radiobiology Group and The University of Manchester
Downloads 19 (1,187,633)

Abstract:

Loading...

prostate cancer, Radiotherapy, Toxicity, Prediction modeling, Voxel-based dose-response analysis (VBA), Organs-at-risk (OAR)